MYGN ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Myriad Genetics, Inc. Shareholders Who Lost Money
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Myriad Genetics, Inc. for potential federal securities law violations. This follows UnitedHealth Group's decision to stop covering Myriad's GeneSight test starting January 1, 2025.
November 10, 2024 | 4:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Myriad Genetics is under investigation for potential securities law violations after UnitedHealth announced it will stop covering the GeneSight test.
The investigation by Levi & Korsinsky and the loss of coverage by UnitedHealth for GeneSight could negatively impact Myriad Genetics' stock price. The legal scrutiny and potential loss of revenue from GeneSight coverage are significant concerns for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100